Member Info for Dibs61

Thanks 5085 great research!

Heavy going but yes very interesting and here is the Conclusion:

“With the rapid advancement of novel therapies targeting the immune checkpoint pathway, there is a pressing need to develop better biomarkers to assess likely clinical response in advance of therapeutic intervention. Here, we report on a novel 3D genomics approach to identify predictive blood-based markers that can identify, with high accuracy, individuals that are likely to respond to PD-(L)1 ICIs monotherapy, especially across tumour types with low ORRs. The 3D genomics approach described here has been developed into a clinical assay to assist in treatment decisions, help improve patient selection for optimised treatment, help better utilise alternative effective treatments, minimise or avoid unnecessarily toxicity, and efficiently manage costs and resources.”

Have to remember that volume is extremely low over the past few weeks.

So even though we’ve dropped back there’s been no substantial selling. Just regular AIM drift on lack of news or impetus.

I think folk are assuming no substantial news now until the big January update where we will def get news on sales. My guess is that we will start to see the SP move in anticipation before the end of the year. Unless we get an ‘unexpected’ (by the market at least) announcement before then which is perfectly possible.

In purely hypothetical terms at this stage To retrospectively cancel approval previously given for tests viz a viz CIRT and PSE seems to me extremely unlikely. This would not be received well in the medical community where these tests are already proving their value and validity and being used by leading doctors.. furthermore the same model and platform (Episwitch) is being used for all OBD’s tests.

I think that ‘IF’ and it is just if at this stage, such a change happened it would have to be from a future date. If nothing else, to give affected companies a chance to prepare. If you went retrospectively what effective date do you pluck out the air? Makes no sense.

DiugWalker - so you now accept that the ‘fact’ you claimed was not a ‘fact’ but just an ‘opinion’. And, as such, you misrepresented it.

That’s progress.

Indeed. Dug attempted to claim that his ‘view’ ‘opinion’ ‘assumption’ call it what you will … was a ‘fact’. Well it ISN’T a fact and I challenge him to be big enough to admit that it wasn’t a fact. Just an opinion.

I bet he won’t.

Most posters who do what he has done o no this board the past day or so would be ‘derided as derampers but he’s been given an easy ride.

I think he must’ve bought high and he has DEFINITELY sold low!! It’s a classic PI error to get spooked in this game. But the remarkable thing is his fixation with an area which is not even part of OBD’s short or even medium term strategy! Check out all their presentations for verification.

There are none so blind as those who cannot see.

Didn’t take long for DugWalkers assumptions to be shot down in flames. Because that’s all they were, an opinion, a view, NOT a FACT.

Stating’When the facts change’ was wholly misleading headline in itself and clearly trying to leverage his claim of being a clinical professional to give his VIEW NOT FACT some level of authority. BS!

Dug, put simply if you think the USA gives a fig about what the UK does viz a viz PSE involvement- or not - in a clinical trial you are majorly misguided imho.

To be clear, the UK was not and is not a strategic priority for OBD re the PSE test. They have stated as much. The big bucks are in the States - for now at least. And I don’t hear much mention of ‘Stockholm3’ over the pond.

Your comment about US patients signing a disclaimer when taking PSE because of some perceived omission from a UK trial practically had me falling off my chair with laughter. Seriously?! I’ve spent quite a lot of time in the States and I have gained an understanding of their mentality. For OBD to make the progress they have already to date in the hardest market in the world to crack is phenomenal for such a small company.

Finally OBD have NOT changed their strategy due to your assumptions regarding inclusion in a clinical trial. The plan has always been to prioritise commercialisation in the USA first.

And it’s clearly making progress.

Oh and I noticed that little cluster of sells seconds after the market opened this morning. I’d wager that was probably you right Dug. It registered with me at the time someone was in a bit of a panic to get out!

Oh and you have already repeated your reason for selling in your sequence of replies to every post so it’s going to get pretty tiresome soon if you keep doing it. We’ve got your point. Fair enough it’s your view. IMHO you’ve got it tragically wrong because it’s NOT about the UK and the US truly couldn’t care less what happens over there! Their private sector is its own entity and if their tests can save money and translate to the bottom line….;)

Amica1 - there has been no ‘SP crash’ what utter nonsense. A retrace yes, a gradual slow pullback yes but NO crash.

Now, if you were daft enough to get spiked at 50p+ that’s your problem. And I rather suspect you might’ve been which would explain your saltiness. Furthermore ‘director selling’ oh my word Amica1 🤦🏼‍♂️Diggle has disposed of a tiny tiny fraction of his shareholding. Almost inconsequential quite frankly. It mean’s nothing. I would concede there have been 9ne or two trading days when the ‘director sells’ (lol) were probably responsible for a fall on the day. But all that does is clarify there are some skittish uninformed )’investors’ out there!

Much like yourself!

Oh and please do go ahead and sell up I’ll have your shares. :)

Perspective for goodness sake! The guy owns 27,431,756 shares in the company and sells…….

125k shares lol.

It is a TINY fraction of his holding. A mere drop in the ocean and makes barely any difference to his percentage holding 13.56%

It is practically inconsequential and mere back pocket money. I agree it is the mere idea of a sell that the market is focusing on currently but all it does is provide an incredible buying opportunity for investors who can see beyond their own noses imho.

It’s not a case of ‘returning’ the licences because they were cancelled. The GSMB have been instructed to issue NEW licences. Whether they will have new conditions attached we don’t know and we also don’t know how long they will take to issue them.

And I strongly believe that the JV will not be formally signed off until the new licences are issued. So yes I agree it is possible it may not happen until into the NY (as much as I hope it is!)

Just picked up some more stock….

10-Nov-23 15:21:38 31.504 12,093 3,810 O

Newland is delusional, incompetent and arrogant.

This is a company on the retreat, contracting and YEARS away from any possibility of break even. Their cash burn remains so high even after the so called ‘streamlining’ lol.

The growth in revenue it has to remembered is from a microscopic level. Doubling the revenue next year will be much much harder unless they get any commercial traction. In some areas of the business, by his own admission, they are going backwards.

Stockraiser- the only ‘evidence’ it provides is of continued and indeed accelerating failure to achieve the kind of revenue growth that was long expected here. Your ‘evidence’ is the SP response this morning.

Closing the US operations is ‘evidence’ of business contraction NOT growth.

Cashburn continues apace.

The revenue growth is from a microscopic level so talk of doubling and trebling is highly misleading for investors with a lack of understanding of the failure of management to deliver here!

So we now know that our persistent seller was a FORCED and entirely discredited shareholder.

Nothing to do with the company, it’s prospects or fundamentals.

They Can only sell once and good riddance. Shares will now be in safer stickier hands, nearly 20% of the company!

This is great news we can push on now.

Agreed. Absolutely it’s just a matter of time….

Very easy for MM’s to control and direct price movements now because of v low volume. They will push the price in a direction which generates most business for them.

However there is imho VERY LITTLE downside from here. We have already seen solid support around the 30/31p mark exactly as I suggested.

Hold firm.

Good morning

We are genuinely ‘up’ in pre market trading. Good sign.

Going by the spread at the time it was 100% a sell. Let’s not mislead ourselves

Looking more like another P&D to me. Tracking back through todays trades I can see plenty of opportunistic trader activity sadly. Many have actually, madly, bailed out for a loss.

Pathetic.

MM’s in firm control here due to v low volume, quiet and no news currently. Their raison d’etre will be to find a price point where this is more business/demand which is why they are edging it down to see where business bites!

That could all change in the blink of an eye.

Well that escalated quickly lol.

The market waking up to a possible $10m milestone payment perhaps? That would equal the current valuation. Crazy. If it happens the SP doubles or even trebles very very quickly.

Unashamed ramp.